2Joshua W,John P.Clinical Effects of Short-term Oral Budesonide on the Hypothalamic-Pituitary-Adrenal Axis in Dogs with Inflammatory Bowel Disease[J].Hosp Assoc,2004,40(2):120-123.
3Carter M,Lobo A.Guidelines for the Management of Inflammatory Bowel Disease in Adults[J].Gut,2004,53(suppl 5):1-16.
4Present DH,Lichtiger S.Efficacy of cyclosporine in treatment of fistula of Crohn's disease[J].Dig Dis Sci,1994,39(2):374-380.
5Rutgeerts P,Feagan BG,Olsen A,et al.A randomized placebocontrolled trial of Infliximab therapy for active ulcerative colitis:Act I trial[J].Gastroenterology,2005,128(4):A105.
6Sandborn WJ,Rachmilewitz D,Hanauer SB,et al.Infliximab induction and maintenance therapy for ulcerative colitis:the Act 2 trial[J].Gastroenterology,2005,128(4):A104.
7Lawson M,Thomas A,Akobeng A,et al.Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis[J].Cochrane Database Syst Rev,2006,3:5112.
8Sandborn WJ,Feagan BG,Hanauer SB,et al.An engineered human antibody toTNF(CDP571)for active Crohn's disease:a randomized double.blind placebo-controlled trial[J].Gastroenterology,2001,120(6):1330-1338.
9Sandborn WJ.Strategies for targeting tumour necrosis factor in IBD[J].Best Pract Res Clin Gastroenterol,2003,17(1):105-117
